A patient arrives at the emergency room with repeated vomiting and bilateral conjunctivitis, without cough or nasal congestion. The rapid antigen test returns positive for SARS-CoV-2. This type of presentation, still marginal two years ago, is increasingly appearing in syndromic surveillance reports in 2026.
Conjunctivitis and vomiting: a COVID picture to identify in the early days
On the ground, we receive patients who consult for red, watery eyes, accompanied by nausea. None of them think of COVID. Surveillance networks like SOS Médecins and Santé publique France have been documenting since the last waves a concomitant increase in conjunctivitis, vomiting, and ENT infections during peaks of SARS-CoV-2 circulation.
This mixed profile contrasts with the classic picture centered on cough and fever. The combination of “sore throat + conjunctivitis + nausea” constitutes a signal of an ongoing wave, rarely mentioned in usual content.
The tropism of recent variants explains this shift. Historical strains targeted deep lung tissue. The lineages circulating today, such as XEC, favor the upper respiratory tract and seem to have broadened their spectrum to ocular and digestive mucous membranes. To better understand the atypical symptoms of COVID 2026, this dual ENT-digestive involvement deserves to be detected early, especially in individuals who might not test based solely on these signs.
Long COVID in 2026: cognitive fatigue and dysautonomia at the forefront
Long COVID has not disappeared with the mitigation of severe forms. The post-infectious profile has changed. Where the first waves primarily left persistent shortness of breath, current forms are dominated by neuro-cognitive fatigue and dysautonomic disorders.
Specifically, patients report, several weeks after an apparently mild infection, debilitating mental fog and fatigue disproportionate to the effort exerted. The Molinari Institute emphasizes that long COVID remains a blind spot in the public debate on sick leave, delaying care.
Post-COVID dysautonomia: signs attributed to stress
Increased heart rate upon simply standing up, inappropriate sweating, thermal regulation disorders. Dysautonomia encompasses these disruptions of the autonomic nervous system. In consultations, they are often attributed to anxiety or overwork, even though they can last for months after infection.
The problem on the ground is that none of these symptoms trigger a COVID screening reflex. A patient consulting for palpitations at rest or postural dizziness will not be systematically questioned about a recent infectious episode. The link between recent infection and dysautonomia must be actively sought by the treating physician.
Recent variants and rapid transmission: what it changes in daily life
The XFG variant is among the dominant lineages observed in 2025-2026. Their tropism directed towards the upper respiratory tract favors rapid transmission in enclosed spaces.
We are contagious early in the course of the infection. Symptoms may appear even before we have the reflex to isolate ourselves, significantly reducing the window of action to protect a vulnerable close contact.
Warning signs not to confuse with a common cold
The confusion with a simple cold or seasonal flu remains the main obstacle to rapid screening. Certain signs should direct towards a COVID test rather than traditional symptomatic treatment:
- Acute sore throat with sudden onset, more intense than a simple tickle, associated with rapid nasal congestion
- Conjunctivitis without identifiable allergic cause, especially if accompanied by ENT symptoms
- Isolated nausea or vomiting in an adult without suspicious dietary context
- Intense and sudden fatigue with mental fog, disproportionate to the general condition
Feedback varies on this point, but several city doctors report that loss of smell, once almost pathognomonic, has become significantly less frequent with current variants. We can no longer rely on this historical marker to decide whether to test or not.
Antigen test or PCR in 2026: what reflex to have in the face of unusual symptoms
When the presentation is atypical (digestive, ocular, neurological), the rapid antigen test remains the first accessible gesture. However, its sensitivity decreases with variants with upper respiratory tropism, as the nasopharyngeal viral load may be lower at the onset of symptoms.
A molecular PCR test in the laboratory offers better reliability if the rapid test returns negative despite persistent signs. The classic nasal self-test, performed too early or with a superficial sample, regularly produces false negatives. Repeating a test 48 hours later in case of persistent symptoms remains the most pragmatic recommendation when the picture does not match an ordinary cold.
SARS-CoV-2 in 2026 circulates quietly, integrated into the surveillance of acute respiratory infections alongside influenza and bronchiolitis. Classic barrier gestures (hand washing, ventilation, wearing a mask in case of symptoms) remain highly relevant. Monitoring isolated digestive or ocular signs, considering COVID in the face of post-infectious cognitive fatigue, and not relying on a single negative self-test when the clinical picture raises concern: this is what makes the difference between a missed diagnosis and appropriate care.